Analytics

Equity Analytics

On the record this week: what the Street published, what insiders filed, and what reports next.

Equity Analytics/CSL.AX

CSL.AX

CSL Limited

Healthcare - AU

CSL Limited is an Australian multinational specialty biotechnology company focused on the research, development, manufacture, and marketing of biopharmaceutical products to treat and prevent rare and serious diseases globally. Its core oper…

HQ: Melbourne, VIC, Australiawww.csl.com

AUD167.10-1.42%vs prev. close

Market snapshot

Price

AUD167.10

Daily move

-1.42%

P/E

—

EPS TTM

-7.40

Dividend yield

2.45%

Beta

0.13

Market cap

57.6B

Price history

CSL.AX price

AUD

VolumeLog scale

No price history available

Next earnings

No upcoming earnings report scheduled in the next 6 months.

Peer comparison

Company	Ticker	Industry	Mkt cap (USD bn)	P/E	Div yld	1W	1M	3M	6M	1Y	YTD
CSL	CSL.AX	Biotechnology	57.6	—	2.45%	-4.2%	+20.7%	+55.4%	+18.5%	-18.8%	-3.2%

Subscribe to Equity Analytics to compare CSL.AX with its closest peers

Sector-matched peer set with side-by-side valuation, dividend and performance over every window.

View plans

Ask Ashenden

One question, one concise answer grounded in Ashenden research.

Built on Ashenden research and our own data. Answers are AI-generated: they can be wrong or incomplete — check anything you would act on.